Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors

被引：35

作者：

Beck, Hilary P. ^{[1
]}

DeGraffenreid, Michael ^{[1
]}

Fox, Brian ^{[1
]}

Allen, John G. ^{[2
]}

Rew, Yosup ^{[1
]}

Schneider, Stephen ^{[3
]}

Saiki, Anne Y. ^{[4
]}

Yu, Dongyin ^{[4
]}

Oliner, Jonathan D. ^{[4
]}

Salyers, Kevin ^{[5
]}

Ye, Qiuping ^{[6
]}

Olson, Steven ^{[1
]}

机构：

[1] Amgen Inc, Chem Res & Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Chem Res & Discovery, Thousand Oaks, CA 91320 USA

[3] Amgen Inc, Chem Res & Discovery, Cambridge, MA 02142 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, PKDM, Thousand Oaks, CA 91320 USA

[6] Amgen Inc, PKDM, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 09期

关键词：

Oncology; Protein-protein interaction; Pharmacokinetics; SMALL-MOLECULE INHIBITORS; CANCER-THERAPY; P53; AMPLIFICATION; APOPTOSIS; STABILITY; BINDING;

D O I：

10.1016/j.bmcl.2010.11.027

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Human murine double minute 2 (MDM2) is a negative regulator of p53, which plays an important role in cell cycle and apoptosis. We report several optimizations to the synthesis of the chromenotriazolopyrimidine series of MDM2-p53 protein-protein interaction inhibitors. Additionally, the in vitro and in vivo stability, pharmacokinetic properties and solubility were improved through N-substitution. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：2752 / 2755

页数：4

共 50 条

[21] Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity
Brandao, Pedro
Loureiro, Joana B.
Carvalho, Sylvie
Hamadou, Meriem Hadjer
Cravo, Sara
Moreira, Joana
Pereira, Daniela
Palmeira, Andreia
Pinto, Madalena
Saraiva, Lucilia
Cidade, Honorina
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 : 711 - 721
[22] Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction
Gureev, Maxim
Novikova, Daria
Grigoreva, Tatyana
Vorona, Svetlana
Garabadzhiu, Alexander
Tribulovich, Vyacheslav
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2020, 34 (01) : 55 - 70
[23] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
Bazanov, Daniil R.
Pervushin, Nikolay, V
Savin, Egor, V
Tsymliakov, Michael D.
Maksutova, Anita, I
Sosonyuk, Sergey E.
Kopeina, Gelina S.
Lozinskaya, Natalia A.
MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (12) : 2216 - 2227
[24] Discovery of Potent and Selective p53-MDM2 Protein-Protein Interaction Inhibitors as Anticancer Drugs
Holzer, Philipp
CHIMIA, 2017, 71 (10) : 716 - 721
[25] Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction
Yu, Ming
Wang, Yingcai
Zhu, Jiang
Bartberger, Michael D.
Canon, Jude
Chen, Ada
Chow, David
Eksterowicz, John
Fox, Brian
Fu, Jiasheng
Gribble, Michael
Huang, Xin
Li, Zhihong
Liu, Jiwen
Lo, Mei-chu
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 894 - 899
[26] A Fluorescent Probe for Imaging p53-MDM2 Protein-Protein Interaction
Liu, Zhenzhen
Miao, Zhenyuan
Li, Jin
Fang, Kun
Zhuang, Chunlin
Du, Lupei
Sheng, Chunquan
Li, Minyong
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (04) : 411 - 417
[27] Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction
Beloglazkina, Anastasia
Zyk, Nikolai
Majouga, Alexander
Beloglazkina, Elena
MOLECULES, 2020, 25 (05):
[28] Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53-MDM2 protein-protein interaction
Beloglazkina, A. A.
Skvortsov, D. A.
Tafeenko, V. A.
Majouga, A. G.
Zyk, N. V.
Beloglazkina, E. K.
RUSSIAN CHEMICAL BULLETIN, 2018, 67 (03) : 562 - 569
[29] Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction
Green, Adam I.
Hobor, Fruzsina
Tinworth, Christopher P.
Warriner, Stuart
Wilson, Andrew J.
Nelson, Adam
CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (47) : 10682 - 10689
[30] Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction
Zhuang, Chunlin
Miao, Zhenyuan
Zhu, Lingjian
Dong, Guoqiang
Guo, Zizhao
Wang, Shengzheng
Zhang, Yongqiang
Wu, Yuelin
Yao, Jianzhong
Sheng, Chunquan
Zhang, Wannian
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9630 - 9642

← 1 2 3 4 5 →